Filing Flows

Filing Flows › LivaNova (LIVN) › Recalls, complaints & regulation

LivaNova (LIVN): recalls, EPA violations and clinical trials

LivaNova (LIVN) beyond its filings: 0 recalls in the last 12 months (8 in five years, 0 Class I); 0 EPA-regulated facilities in violation, $7K in penalties over five years; 2 active clinical trials.

Latest recalls

LivaNova's latest quarter

LivaNova, Q3 2026: revenue $393M (+10% year over year), operating margin 7.2%, net earnings $34.3M, operating cash flow $73.7M. The chart follows the revenue to costs, profit and cash.

Questions

Has LivaNova had any recalls?

8 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

Has LivaNova been fined by the EPA?

The 1 EPA-regulated facility on file under its name drew $7K in penalties over five years; 0 are in violation now.

How many clinical trials does LivaNova have?

2 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.